PHA Corporate Committee

We offer special thanks to those companies that have stepped forward and are fulfilling a special responsibility to the PH community by joining our Corporate Committee. Through this Committee, the members work together toward solutions to a wide variety of issues, including raising public visibility of PH and supporting education needs of the patient and medical community.

Structure

In addition to its dues-paying corporate members, the PHA Corporate Committee includes representation from the PHA Board of Trustees, PHA’s Scientific Leadership Council and PH Professional Network (formerly PH Resource Network), as well as PHA’s President.


Member Companies

  • Actelion Pharmaceuticals US, Inc.
  • Bayer HealthCare
  • CVS Caremark
  • Accredo
  • Gilead Sciences, Inc.
  • GlaxoSmithKline
  • Lung LLC
  • Medtronic, Inc.
  • Reata Pharmaceuticals, Inc. 
  • SteadyMed Therapeutics
  • United Therapeutics Corporation
  • Walgreens

Leadership

Chair
Denise Bagford, RN, BSN, CRNI
CVS Caremark

Chair-Elect
Gareth Gwyn
Bayer HealthCare

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
Webmaster@PHAssociation.org
    Privacy Policy   Virtual Tour of Website    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2014 Pulmonary Hypertension Association. All Rights Reserved.

NORD

The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.